Literature DB >> 6757272

Modification of the system of screening for antisyphilis antibodies in a blood transfusion centre, featuring a miniaturisation of the Treponema pallidum haemagglutination assay.

A Puckett, G Pratt.   

Abstract

A modified, miniaturised version of the Fujizoki Treponema pallidum haemagglutination assay (TPHA) is described. The method is fast, sensitive, specific, and very economical. During a test period of one year, use of the method gave rise to a 67% increase in confirmed positives among new donor sera and a 112.5% increase among the antenatal sera over the numbers that would have been detected using a cardiolipin test alone. With the new donor sera, the rate of confirmed positives detected during the test period was 150% greater than that of 1980, when a cardiolipin test alone was used (0.05 greater than p greater than 0.02 (chi 2 test)).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757272      PMCID: PMC497976          DOI: 10.1136/jcp.35.12.1349

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  A modification of Hepatest, using the Terasaki plate, for the detection of HBSAg in blood donors.

Authors:  I C Wiseman
Journal:  J Clin Pathol       Date:  1976-03       Impact factor: 3.411

2.  Specificity, sensitivity, and diagnostic value of the TPHA test.

Authors:  J Lesiński; J Krach; E Kadziewicz
Journal:  Br J Vener Dis       Date:  1974-10

3.  Treponema pallidum haemagglutination test as a screening procedure for the diagnosis of syphilis.

Authors:  H Young; C Henrichsen; D H Robertson
Journal:  Br J Vener Dis       Date:  1974-10

4.  Treponema pallidum haemagglutination test for syphilis. Comparison with TPI and FTA-ABS tests.

Authors:  M F Garner; J L Backhouse; G Daskalopoulos; J L Walsh
Journal:  Br J Vener Dis       Date:  1972-12

5.  Treponema pallidum haemagglutination test for syphilis. Evaluation of a modified micro-method.

Authors:  N A Johnston
Journal:  Br J Vener Dis       Date:  1972-12

6.  Appraisal of the Treponema pallidum haemagglutination test.

Authors:  A Luger; I Spendlingwimmer
Journal:  Br J Vener Dis       Date:  1973-04

7.  Treponemal haemagglutination test.

Authors:  P J Sequeira; A E Eldridge
Journal:  Br J Vener Dis       Date:  1973-06

8.  Haemagglutination test utilizing pathogenic Treponema pallidum for the sero-diagnosis of syphilis.

Authors:  T Rathlev
Journal:  Br J Vener Dis       Date:  1967-09

9.  Early TPHA response in primary syphilis.

Authors:  A E Jephcott; M A Beveridge; P J Sequeira
Journal:  Br J Vener Dis       Date:  1977-04

10.  Comparison between the automated reagin test and reagin screen test methods of VDRL screening tests for syphilis in use in a routine laboratory.

Authors:  R D Simon; A M Peacock
Journal:  J Clin Pathol       Date:  1977-07       Impact factor: 3.411

View more
  5 in total

1.  Syphilis screening in the Blood Transfusion Service: a report of four years' experience with the Treponema pallidum haemagglutination assay and the subsequent development of a rapid "spin" method.

Authors:  A Puckett; G Pratt
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

2.  Comparative trial of six methods for the detection of CMV antibody in blood donors.

Authors:  A F Hunt; D L Allen; R L Brown; B A Robb; A Y Puckett; C C Entwistle
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

3.  TPHA compared with cardiolipin tests for serological detection of early primary syphilis.

Authors:  J Barbara; R Salker; F Lalji; P Mochnaty
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

4.  Donor screening for antibody to hepatitis B surface antigen.

Authors:  S M Lake; A Y Puckett; C C Entwistle
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

5.  Serological screening tests for syphilis in pregnancy: results of a five year study (1983-87) in the Oxford region.

Authors:  P Bowell; K Mayne; A Puckett; C Entwistle; J Selkon
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.